Safi Biotherapeutics
PrivateLast Round
Grant
Apr 24, 2025
Total Funding Raised
$9.07M
Company Overview
Safi Biotherapeutics is a biotechnology company developing manufactured red blood cell (mRBC) therapies from stem cells for transfusion needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Defense Tech, Smart Manufacturing
Business Model
B2B
Customer Profile
Government Contracts, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Safi Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
Safi Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 24, 2025 | ||||
| Grant | Feb 25, 2025 | ||||
| Seed | Sep 11, 2024 |
Key People
Founding team and executive leadership
Safi Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| U.S. Department of Defense | Grant |
| J2 Ventures | Seed |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
Partnered with DesiCorp Inc. to support freeze-drying of mRBCs.
Safi Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Safi Biotherapeutics's valuation, stock price, and market status.
